These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10789078)

  • 1. [Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma].
    Somlai B; Holló P
    Hautarzt; 2000 Mar; 51(3):173-5. PubMed ID: 10789078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
    Parker CM; Hanke CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional interferon alfa-2b treatment of keratoacanthomas.
    Oh CK; Son HS; Lee JB; Jang HS; Kwon KS
    J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S177-80. PubMed ID: 15577764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large keratoacanthomas treated with intralesional interferon alfa-2a.
    Grob JJ; Suzini F; Richard MA; Weiller M; Zarour H; Noe C; Munoz MH; Bonerandi JJ
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):237-41. PubMed ID: 8335744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of keratoacanthoma with intralesional methotrexate injections].
    Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
    Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of multiple keratoacanthoma centrifugum marginatum.
    Mangas C; Bielsa I; Ribera M; Fernández-Figueras MT; Ferrándiz C
    Dermatol Surg; 2004 May; 30(5):803-6. PubMed ID: 15099330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant keratoacanthoma-type low-grade squamous cell carcinoma of the upper lip: Response to intralesional interferon alpha-2B.
    Anadolu R; Akay BN; Bodamyali P; Akyol A
    J Dermatolog Treat; 2011 Aug; 22(4):239-40. PubMed ID: 20666675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Keratoacanthoma centrifugum marginatum].
    Chaffai M; Houman MH; Haouet S; Ben Osman A
    Ann Dermatol Venereol; 1994; 121(10):731-3. PubMed ID: 7793766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
    Remling R; Mempel M; Schnopp N; Abeck D; Ring J
    Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of Ufudix ointment for the treatment of keratoacanthoma. I. Clinical evaluation of the results].
    Starzycki Z
    Przegl Dermatol; 1980; 67(4):469-74. PubMed ID: 7001547
    [No Abstract]   [Full Text] [Related]  

  • 12. Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge.
    Divers AK; Correale D; Lee JB
    Cutis; 2004 Apr; 73(4):257-62. PubMed ID: 15134326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of etretinate (Tegison; Tigason) in the management of keratoacanthoma.
    Cristofolini M; Piscioli F; Zumiani G; Scappini P
    J Am Acad Dermatol; 1985 Apr; 12(4):633-8. PubMed ID: 3989024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
    Aroni K; Mastoraki A; Agrogiannis G; Ioannidis E; Patsouris E
    Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
    [No Abstract]   [Full Text] [Related]  

  • 16. Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results.
    Blasi MA; Tiberti AC; Valente P; Laguardia M; Sammarco MG; Balestrazzi A; Larocca LM; Balestrazzi E
    Ophthalmology; 2012 Mar; 119(3):494-500. PubMed ID: 22226154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Chitwood K; Etzkorn J; Cohen G
    Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
    Dendorfer M; Oppel T; Wollenberg A; Prinz JC
    Eur J Dermatol; 2003; 13(1):80-2. PubMed ID: 12609789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of podophyllin in the treatment of keratoacanthoma.
    Cipollaro VA
    Int J Dermatol; 1983 Sep; 22(7):436-40. PubMed ID: 6629612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.